STOCK TITAN

Profusa (PFSA) investors disclose 9.99% blocked stake via notes and ELOC

(Neutral)
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

A group of investment entities and individuals led by Ascent Partners Fund LLC reports beneficial ownership of Profusa, Inc. common stock. The group has shared voting and dispositive power over 58,749 shares of common stock, representing 9.99% of the class as of June 30, 2026, subject to a contractual ownership cap.

The stake arises from convertible promissory notes effective on several dates and a Securities Purchase Agreement (the ELOC Agreement) that allows Profusa, at its option and subject to a 9.99% beneficial ownership limitation (the Blocker), to require purchases of common stock. Ownership percentages are calculated using 186,411 shares outstanding as of May 12, 2026, adjusted for a 1-for-25 reverse stock split effective July 7, 2026, plus shares issuable upon partial note conversions and ELOC purchases, all constrained by the Blocker.

Positive

  • None.

Negative

  • None.
Beneficially owned shares 58,749 shares Shares over which the reporting group has shared voting and dispositive power as of June 30, 2026
Beneficial ownership percentage 9.99% Portion of Profusa common stock beneficially owned by the reporting group, limited by the Blocker
Shares outstanding baseline 186,411 shares Profusa common stock outstanding as of May 12, 2026, adjusted for 1:25 reverse split
Reverse split ratio 1-for-25 Reverse stock split of Profusa common stock effective July 7, 2026
Blocker limit 9.99% Maximum aggregate beneficial ownership allowed under the Convertible Notes and ELOC Agreement
Shares underlying notes at Blocker 58,749 shares Maximum common shares issuable under Convertible Notes up to the Blocker as of June 30, 2026
Convertible Notes financial
"shares of Common Stock to be issued upon (a) conversions of convertible promissory notes"
Convertible notes are a type of short-term loan that a company receives from investors, which can later be turned into company shares instead of being paid back in cash. They matter to investors because they offer a way to support a company early on while giving the potential to own a stake in its success if the company grows and later raises more funding.
Securities Purchase Agreement financial
"purchases by the reporting person pursuant to that certain Securities Purchase Agreement"
A securities purchase agreement is a written contract between a buyer and a seller outlining the terms for buying or selling financial assets such as stocks or bonds. It specifies details like the price, quantity, and conditions of the transaction, similar to a shopping list with agreed-upon terms. For investors, it provides clarity and legal protection when transferring ownership of these financial instruments.
beneficial ownership limitation financial
"subject to a maximum 9.99% beneficial ownership limitation contained therein"
A beneficial ownership limitation is a rule that caps the percentage of a company’s shares an investor can be treated as owning or controlling for voting, regulatory or tax purposes. It matters to investors because it can restrict how many shares a person or group can buy or vote, affect takeover chances, and influence share liquidity and value — like a speed limit that prevents any single driver from taking over the whole road.
reverse stock split financial
"as adjusted for the one-for-twenty-five (1:25) reverse stock split the Company effected"
A reverse stock split reduces a company's number of outstanding shares while raising the price per share proportionally, so the total value of each investor's holding is unchanged; a 1-for-10 split turns 100 shares worth $1 each into 10 shares worth $10 each. Companies often do this to regain compliance with an exchange's minimum price rule or to attract investors who avoid very low-priced stocks.
beneficially own financial
"may be deemed to beneficially own, and have the power to vote, the shares"
Beneficially own means having the economic rights and risks of a security—such as the right to receive dividends, sell the shares, or profit from price changes—whether or not your name appears on the official share register. Think of it like renting a car: you use it and reap the benefits even if the title lists someone else. Investors care because beneficial ownership determines who truly controls value, must be disclosed under securities rules, and can signal potential influence or trading activity that affects a stock’s price.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What percentage of Profusa (PFSA) common stock does the reporting group own?

The reporting group beneficially owns 9.99% of Profusa’s common stock. This percentage is calculated including shares issuable from convertible notes and the ELOC Agreement, but capped by a 9.99% beneficial ownership limitation.

How many Profusa (PFSA) shares are attributed to the reporting group?

The group has shared power over 58,749 shares of Profusa common stock. These shares include stock underlying convertible promissory notes and potential purchases under the ELOC Agreement, all limited by the 9.99% ownership cap.

What base share count did the Profusa (PFSA) investors use to compute ownership?

Ownership was calculated using 186,411 shares of Profusa common stock outstanding as of May 12, 2026. This figure is adjusted for a 1-for-25 reverse stock split that Profusa effected on July 7, 2026.

What is the 9.99% Blocker mentioned for Profusa (PFSA) investors?

The 9.99% Blocker is a contractual limit in the Convertible Notes and ELOC Agreement. It prevents the reporting group from converting or purchasing shares to a level where their beneficial ownership would exceed 9.99% of Profusa’s outstanding common stock.

How is the Profusa (PFSA) investment structured for the reporting group?

The investment is structured through convertible promissory notes and an ELOC Agreement. These instruments allow issuance or purchase of Profusa shares up to the Blocker, with shared voting and dispositive power over 58,749 underlying shares.

Who are the key entities in the Profusa (PFSA) reporting group?

Key entities include Ascent Partners Fund LLC, Ascent Partners LLC, Dominion Capital LLC, Dominion Capital GP LLC, Eagle Claw Corp., Masada Group Holdings LLC, and individuals Mikhail and Gennadiy Gurevich and Alon Brenner, who collectively manage and control the holdings.





74319X207

(CUSIP Number)
06/30/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of common stock, par value $0.0001 per share, of the issuer (the "Common Stock") set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount (as defined in this footnote), the shares of Common Stock to be issued upon (a) conversions of convertible promissory notes (the "Convertible Notes"), effective April 20, 2026, April 2, 2026, July 11, 2025 and December 29, 2023 respectively, held directly by the reporting person and (b) purchases by the reporting person pursuant to that certain Securities Purchase Agreement, dated as of July 28, 2025 and amended on December 22, 2025, between the issuer and the reporting person (the "ELOC Agreement") whereby, subject to certain conditions, the issuer may, at its option but subject to the Blocker Amount, require the reporting person to purchase Common Stock. The Convertible Notes and ELOC Agreement are all subject to a maximum 9.99% beneficial ownership limitation contained therein (the "Blocker Amount"). In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement on Schedule 14A filed with the U.S. Securities and Exchange Commission (the "SEC") on May 26, 2026 (the "Definitive Proxy Statement") and as adjusted for the one-for-twenty-five (1:25) reverse stock split the Company effected on July 7, 2026 (the "Reverse Stock Split") and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes, and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Note and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G




Comment for Type of Reporting Person: The percentage set forth on row (11) above and the number of shares of Common Stock set forth on rows (6), (8) and (9) above includes, up to the Blocker Amount, the shares of Common Stock to be held indirectly by the reporting person upon (a) conversions of the Convertible Notes and (b) purchases pursuant to the ELOC Agreement. The Convertible Notes and ELOC Agreement are all, in the aggregate, limited by the Blocker Amount. In Row (11) the percentage is based on (i) 186,411 shares of Common Stock outstanding as of May 12, 2026, as reported by the issuer in its Definitive Proxy Statement and as adjusted for the Reverse Stock Split and (ii) shares of Common Stock issued upon partial conversion of the Convertible Notes and the purchase of some Common Stock pursuant to the ELOC Agreement, in each case subject to the Blocker Amount.


SCHEDULE 13G



Ascent Partners Fund LLC
Signature:/s/ Ascent Partners Fund LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member of Managing Member
Date:08/04/2026
Ascent Partners LLC
Signature:/s/ Ascent Partners LLC
Name/Title:Mikhail Gurevich, signatory for Managing Member
Date:08/04/2026
Dominion Capital LLC
Signature:/s/ Dominion Capital LLC
Name/Title:Mikhail Gurevich, Chief Investment Officer of Eagle Claw Corp., Manager of Dominion Capital GP LLC, Manager of Dominion Capital LLC
Date:08/04/2026
Dominion Capital GP LLC
Signature:/s/ Dominion Capital GP LLC
Name/Title:Mikhail Gurevich, Chief Investment Officer of Eagle Claw Corp., Manager of Dominion Capital GP LLC
Date:08/04/2026
Eagle Claw Corp.
Signature:/s/ Eagle Claw Corp.
Name/Title:Gennadiy Gurevich, President
Date:08/04/2026
Masada Group Holdings LLC
Signature:/s/ Masada Group Holdings LLC
Name/Title:Alon Brenner, Managing Member
Date:08/04/2026
Mikhail Gurevich
Signature:/s/ Mikhail Gurevich
Name/Title:Mikhail Gurevich
Date:08/04/2026
Gennadiy Gurevich
Signature:/s/ Gennadiy Gurevich
Name/Title:Gennadiy Gurevich
Date:08/04/2026
Alon Brenner
Signature:/s/ Alon Brenner
Name/Title:Alon Brenner
Date:08/04/2026

Comments accompanying signature: LIST OF EXHIBITS Exhibit No. 1 - Joint Filing Agreement, dated June 5, 2026 (incorporated by reference to Exhibit 1 to the Schedule 13G/A filed by the Reporting Persons with the SEC on June 5, 2026)